Today: 10 June 2026
Macquarie Group share price slides after Friday rout — what to watch before Feb 10 briefing
8 February 2026
1 min read

Macquarie Group share price slides after Friday rout — what to watch before Feb 10 briefing

SYDNEY, Feb 8, 2026, 16:59 AEDT — The session wrapped up with the market now closed.

  • Macquarie finished the session 2.17% lower at A$207.83.
  • Friday saw the ASX 200 tumble 2%, with losses hitting stocks across the board.
  • Attention now turns to markets reopening Monday, with Macquarie’s operational briefing set for Feb. 10.

Macquarie Group Ltd (MQG.AX) ended Friday down 2.17% at A$207.83, with pressure on Australian stocks dragging shares lower. Roughly 896,000 Macquarie shares changed hands during the session, trading between A$206.76 and A$210.99.

Macquarie stands out: it trades with the valuation of both a bank and a markets player. That dual identity has consequences when investors pull back. On one hand, risk appetite drops and deal flow slows. On the other, trading desks face a surge in volatility to work through.

With the ASX closed for the weekend, direction falls to offshore moves and futures. Come Monday, traders will be gauging fast whether Friday’s drop was just a blip or the opening act of something more volatile.

The S&P/ASX 200 in Australia dropped 2%, losing roughly 180 points to close at 8,709 on Friday. Every sector ended in the red. “Panic is spreading,” said MooMoo Australia’s Michael McCarthy. “The combination of so many markets falling at the same time is unnerving investors.” ABC News

Macquarie put out a new filing on its investment activity, revealing it crossed the “substantial holder” mark in Sandfire Resources as of Feb. 3. The group picked up 23,136,042 shares, giving it 5.01% of voting rights — just enough to prompt a Form 603 under Australian rules. Company Announcements

Regulators are still in the picture. Australia’s APRA loosened some of the additional liquidity rules it slapped on Macquarie Bank following a compliance review this week, but left the rest unchanged.

Macquarie’s next big event lands soon. The firm plans to host an operational briefing on Feb. 10, its investor calendar shows.

It’s not an earnings day, but clear words from management on market conditions could sway sentiment. Investors are tuning in for any clues about trends in its markets division, the speed of capital raisings, or shifts in how they’re discussing asset-management flows.

The move isn’t necessarily all in one direction. Should the global rout worsen, higher-beta financials may still lose ground—even if there’s no fresh news from those firms. Add in Macquarie’s sensitivity to market swings, and the impact could feel even sharper.

Stock Market Today

  • 3 High ROE Stocks With Solid Balance Sheets Highlighted for Investors
    June 10, 2026, 9:01 AM EDT. Investors seeking stability amid inflation and geopolitical tensions may focus on companies with high return on equity (ROE) and robust balance sheets. Regis Resources (ASX:RRL) stands out with a 25.7% ROE, strong revenue from Australian gold projects, and forecasts of earnings growth above 20%. However, it faces risks from gold price fluctuations and project approvals. Aristocrat Leisure (ASX:ALL) features as a global gaming technology leader with substantial revenue streams and solid financial fundamentals. These stocks provide potential resilience against margin pressure and volatile input costs, offering a grounded starting point for quality-focused investment research.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland
Previous Story

Fortescue share price set for Monday test as Cyclone Mitchell shuts Port Hedland

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026
Next Story

Windows 11 printer alert: Microsoft tightens the screws on legacy V3/V4 drivers in 2026

Go toTop